SCHEDULE: BlackRock Reports 9.0% Stake in CareDx Inc.

Sentiment:

Ownership Filing


BlackRock, Inc. has disclosed a beneficial ownership of 9.0% in CareDx Inc. common stock as of June 30, 2026.

Summary

  • BlackRock, Inc. has filed a Schedule 13G, indicating a significant ownership stake in CareDx Inc.
  • The filing, dated June 30, 2026, shows BlackRock beneficially owns 4,664,092 shares of CareDx Inc. common stock.
  • This represents 9.0% of the class of securities.
  • BlackRock has sole voting power over 4,575,539 shares and sole dispositive power over 4,664,092 shares.
  • No other person is known to have the right to receive or the power to direct the receipt of dividends or proceeds from the sale of these securities, with no single interest exceeding five percent.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates significant institutional interest from a major player, but provides no operational or financial updates from the company itself.

Positives

  • BlackRock, a major institutional investor, holds a substantial 9.0% stake in CareDx Inc., suggesting confidence in the company's long-term prospects.
  • The clear reporting of sole voting and dispositive power indicates straightforward control over these shares.

Future Outlook

This filing is a disclosure of current ownership and does not contain forward-looking statements or guidance from CareDx Inc.

Industry Context

StockSavvy.ai notes that significant stake disclosures by large asset managers like BlackRock often signal institutional conviction in a company's market position or growth potential within the diagnostics and healthcare technology sector.

Stakeholder Impact

  • Shareholders: The disclosure of a significant stake by BlackRock may be viewed positively, potentially indicating institutional support and confidence in the company's value.
  • Management: The filing confirms a substantial institutional investor's presence, which can influence strategic decisions and governance considerations.

Key Dates

DateDescription
01/21/2025Date of Power of Attorney for BlackRock, Inc.
04/30/2023Previous Power of Attorney revoked by BlackRock, Inc.
06/30/2026Date of Event Requiring Filing of Schedule 13G
07/27/2026Date of Signature on Schedule 13G filing

Keywords

CareDx Inc., BlackRock, Schedule 13G, Institutional Investor, Ownership Stake, Common Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.